Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Clorox (CLX) Beats Q2 Earnings & Sales Estimates, Stock Up

Published 02/04/2020, 04:07 AM
Updated 07/09/2023, 06:31 AM

The Clorox Company (NYSE:CLX) reported second-quarter fiscal 2020 results, wherein both earnings and sales beat estimates. Further, the company updated its view for fiscal 2020.

Shares of Clorox increased around 2% in the pre-market session after the robust earnings results. In the past three months, shares of the company have increased 5.4% outperforming the industry’s 4.6% growth.

Q2 Highlights

Quarterly earnings from continuing operations of $1.46 per share increased around 4% year over year and beat the Zacks Consensus Estimate of $1.31. The bottom-line beat was mainly driven by increase in gross margin.

This Zacks Rank #4 (Sell) company posted net sales of $1,449 million, which declined nearly 2% year over year but surpassed the Zacks Consensus Estimate of $1,429 million. Further, sales remained flat on an organic basis. The soft top-line result was caused by unfavorable currency. Currency headwinds hurt sales by nearly 2 percentage points.

The Clorox Company Price, Consensus and EPS Surprise

Driven by the recent price increases and cost savings, Clorox witnessed gross margin expansion of 40 bps to 44.1% in the fiscal second quarter. This marked the company’s fifth straight quarter of gross margin expansion. The rise in gross margin was driven by gains from cost savings and price increases. However, the gains were marred by higher trade promotion spending as well as increased manufacturing and logistics costs.

Segmental Discussion

Sales of the Cleaning segment remained flat at $501 million on decline in Laundry and unfavorable mix from strong growth in non-tracked channels. However, this was offset by growth in Professional Products and Home Care businesses.

The Household segment’s sales declined around 8% to $360 million mainly due to declines in Grilling, and Bags and Wraps businesses. Bags and Wraps sales were impacted by increased competitive activity as well as distribution losses. Further, the Grilling business delivered soft sales due to lower shipments in order to finish working through elevated retail inventory from the prior year. This was partially offset by sturdy consumption growth.

Sales at the Lifestyle segment rose 4% to $347 million. Results were aided by growth in the Natural Personal Care business, driven by innovation in Burt's Bees Lip Care and Face Care categories. Also, the Food and Water Filtration businesses contributed to segment sales growth.

At the International segment, sales decreased 2% to $241 million from the year-ago quarter. The segment sales were negatively impacted by adverse currency fluctuations to the tune of 8 percentage points mainly from Argentina, partly offset by gains of favorable price mix. Organic sales for the segment rose 6%.

Financials

Clorox ended the fiscal second quarter with cash and cash equivalents of $168 million, and long-term debt of $2,288 million. For the first six months of fiscal 2020, the company generated $498 million of net cash from continuing operations.

Fiscal 2020 Guidance

Clorox updated its outlook for fiscal 2020. It continues to project sales between low-single digits decline and up 1% in fiscal 2020. This indicates a slightly more favorable foreign exchange impact, offset by improved promotional spending.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

However, it now expects organic sales growth of flat to 2%, compared 1-3% growth mentioned earlier. The current Zacks Consensus Estimate for fiscal 2020 sales is pegged at $6.17 billion.

Gross margin is now estimated to be slightly up driven by lower input costs. The company had earlier projected gross margin decline for fiscal 2020. Advertising and sales promotion spending is now anticipated to be more than 10% of sales. Selling and administrative expenses are still projected to be nearly 14% of sales. The company continues to envision effective tax rate of 22-23% for fiscal 2020.

Management now anticipates earnings per share of $6.10-$6.25 for fiscal 2020, compared with $6.05-$6.25 expected earlier. The current Zacks Consensus Estimate for fiscal 2020 earnings is pegged at $6.14.

3 Stocks to Consider

Helen of Troy Ltd. (NASDAQ:HELE) presently has an expected long-term earnings growth rate of 9.3% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Procter & Gamble Company (NYSE:PG) has a long-term earnings growth rate of 7.6% and carries a Zacks Rank #2 (Buy).

General Mills, Inc. (NYSE:GIS) has a long-term earnings growth rate of 7%. Currently, it carries a Zacks Rank #2.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.7% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Helen of Troy Limited (HELE): Free Stock Analysis Report

General Mills, Inc. (GIS): Free Stock Analysis Report

Procter & Gamble Company (The) (PG): Free Stock Analysis Report

The Clorox Company (CLX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.